Contact
Please use this form to send email to PR contact of this press release:
SciCann Therapeutics receives notice of allowance for its enhanced CBD therapy US patent for NASH
TO:
Please use this form to send email to PR contact of this press release:
SciCann Therapeutics receives notice of allowance for its enhanced CBD therapy US patent for NASH
TO: